undefinedXbira Tablets

undefinedXbira Tablets Specification

Indication
Metastatic castration-resistant prostate cancer (mCRPC)

Origin
India

Dosage Form
Tablet

Salt Composition
Abiraterone Acetate

Enzyme Types
undefinedXbira Tablets

Feature
High bioavailability, clinical grade, prescription only

Application
Oral administration for prostate cancer treatment

Physical Color/Texture
White to off-white, oblong-shaped tablet

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Packaging Size
120 tablets per bottle

Box Type
HDPE Bottle with child-resistant cap

Strength
250 mg

Contraindications
Contraindicated in women and children

ATC Code
L02BX03

Patient Population
Adult males

Prescription Status
Prescription required

Excipients
Contains lactose and other stabilizers

Route of Administration
Oral

undefinedXbira Tablets Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About undefinedXbira Tablets

Xbira 250mg Tablet is used in the treatment of prostate cancer. Abiraterone acetate belongs to a class drugs known as antiandrogens. It stops the body from making which can slow the growth of prostate cancer

Comprehensive Cancer Care for Men

undefinedXbira Tablets are specially designed for adult males battling metastatic castration-resistant prostate cancer (mCRPC). With high clinical significance, these tablets ensure reliable and effective oral administration, supporting patients with advanced needs.

Quality, Safety, and Convenience

Packaged in a durable HDPE bottle with a child-resistant cap, undefinedXbira Tablets maintain their integrity and safety. Their formulation ensures high bioavailability and a long shelf life when stored correctly, making them a dependable choice for ongoing cancer management.

FAQ's of undefinedXbira Tablets:

Q: How should undefinedXbira Tablets be taken for optimal results?

A: undefinedXbira Tablets should be taken orally as prescribed by a healthcare professional. The recommended dosage and timing will be determined by your doctor, and it is essential to follow their instructions carefully for the best possible outcomes.

Q: What condition are undefinedXbira Tablets used to treat?

A: undefinedXbira Tablets are indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult male patients.

Q: When is undefinedXbira contraindicated?

A: undefinedXbira Tablets are contraindicated in women and children. They are specifically formulated and approved for use in adult male patients only.

Q: Where should I store undefinedXbira Tablets to maintain their quality?

A: Store undefinedXbira Tablets in a cool, dry place inside their original HDPE bottle with a child-resistant cap. Keeping the medication away from excessive heat and moisture preserves its shelf life and effectiveness.

Q: What is the process to obtain undefinedXbira Tablets?

A: A valid prescription from a qualified healthcare professional is required to obtain undefinedXbira Tablets. After consultation, you can purchase them from authorized pharmacies, exporters, suppliers, or traders.

Q: What are the benefits of using undefinedXbira Tablets?

A: undefinedXbira Tablets offer high bioavailability and clinical-grade strength, enhancing the treatment of advanced prostate cancer with a reliable and efficient oral dosage form. Their child-resistant packaging and long shelf life add safety and convenience.

Q: Are there any important excipients in undefinedXbira Tablets that patients should be aware of?

A: Yes, undefinedXbira Tablets contain lactose and other stabilizers as excipients. Patients with lactose intolerance should inform their healthcare provider before starting treatment.

Tell us about your requirement